Vanguard Group Inc Better Therapeutics, Inc. Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.14 - $0.39 $42,244 - $117,679	-301,743 Reduced 60.36%	198,154 $39,000
Q3 2023 Nov 14, 2023	BUY	$0.34 - $1.23 $20,882 - $75,544	61,418 Added 14.01%	499,897 $184,000
Q1 2023 May 15, 2023	BUY	$0.64 - $1.45 $2,368 - $5,365	3,700 Added 0.85%	438,479 $306,000
Q4 2022 Feb 10, 2023	BUY	$1.1 - $1.74 $148 - $234	135 Added 0.03%	434,779 $478,000
Q3 2022 Nov 14, 2022	BUY	$1.53 - $2.77 $154,679 - $280,041	101,098 Added 30.31%	434,644 $765,000
Q2 2022 Aug 12, 2022	BUY	$0.91 - $2.34 $44,727 - $115,013	49,151 Added 17.28%	333,546 $520,000
Q1 2022 May 13, 2022	BUY	$1.98 - $5.01 $159,653 - $403,971	80,633 Added 39.57%	284,395 $563,000
Q4 2021 Feb 14, 2022	BUY	$4.58 - $17.14 $933,229 - $3.49 Million	203,762 New	203,762 $947,000

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.